Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Greenwich LifeSciences (GLSI) Assets Average (2020 - 2025)

Greenwich LifeSciences filings provide 6 years of Assets Average readings, the most recent being $3.5 million for Q3 2025.

  • Quarterly Assets Average fell 46.89% to $3.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Sep 2025, down 46.89% year-over-year, with the annual reading at $5.5 million for FY2024, 45.83% down from the prior year.
  • Assets Average hit $3.5 million in Q3 2025 for Greenwich LifeSciences, up from $2.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $30.1 million in Q2 2021 and bottomed at $2.9 million in Q2 2025.
  • Average Assets Average over 5 years is $14.0 million, with a median of $11.4 million recorded in 2023.
  • The largest annual shift saw Assets Average surged 60.62% in 2021 before it plummeted 53.87% in 2025.
  • Greenwich LifeSciences' Assets Average stood at $28.1 million in 2021, then crashed by 48.12% to $14.6 million in 2022, then crashed by 44.57% to $8.1 million in 2023, then plummeted by 38.56% to $5.0 million in 2024, then crashed by 30.11% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Assets Average are $3.5 million (Q3 2025), $2.9 million (Q2 2025), and $3.4 million (Q1 2025).